Themis Medicare has started supply of its research based product, for pain management (API - Aceclofenac based injection) to a Indian Pharma major, under long term agreement. Themis is the first company to develop this injection which is IPR protected.
Themis Medicare is also engaged in supplying its research formulations to well known Pharmaceutical companies in India namely Alkem Lab, Fulford, Intas Pharmaceuticals, IPCA Lab, Cadila Healthcare, Aristo Pharma, Mankind Pharma, Shreya Lifesciences, Nicholas Piramal, Unichem Lab, etc.
